What's breaking now, across thousands of outlets.
UCLA researchers have identified a pathway in liver cells that may explain how statins could help prevent or slow the development of liver cancer associated with fatty liver disease.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
(MedPage Today) -- Adding the BCL2 inhibitor venetoclax (Venclexta) to chemoimmunotherapy led to worse outcomes and excess mortality in patients with newly diagnosed double-hit lymphoma, phase II…
The death of a Canberra woman is the first in the ACT to be linked to a synthetic opioid which is estimated to be at least 100 times stronger than heroin, a coroner has found.
The CDC said it has received a rise in reports of human rabies exposure cases this summer, prompting an alert to healthcare providers.
The top court orally said that the PIL was filed with an ulterior motive and lacked bonafide
In this GEN webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology. The post Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC…
The report, titled “Expanding Reach, Readiness and Resilience: Data-Driven Health Systems Across Africa,” indicates that the vaccination figure was part of a broader set of interventions implemented…
